Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice - PubMed (original) (raw)

Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice

H J Field et al. Antimicrob Agents Chemother. 1979 Apr.

Abstract

Systemic treatment of mice with the nucleoside analog 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine [aciclovir]) was found to be highly effective against acute type 1 herpes simplex virus infection of the pinna. The drug ablated clinical signs and reduced virus replication both in tissue local to the inoculation site and within the nervous system. Provided that moderate-sized virus inocula were used, acycloguanosine treatment reduced or prevented the establishment of a latent infection in the dorsal root ganglia relating to the sensory nerve supply of the ear. However, although it aborted artificially produced infections in dorsal root ganglia, acycloguanosine was found not to be effective against the latent infection once established. This finding strongly indicated that latent herpes simplex virus in mice can exist in a nonreplicating form.

PubMed Disclaimer

Similar articles

• Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.
  Klein RJ, Friedman-Kien AE, DeStefano E. Klein RJ, et al. Antimicrob Agents Chemother. 1979 May;15(5):723-9. doi: 10.1128/AAC.15.5.723. Antimicrob Agents Chemother. 1979. PMID: 230784 Free PMC article.
• Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
  Al-Saadi SA, Gross P, Wildy P. Al-Saadi SA, et al. J Gen Virol. 1988 Feb;69 ( Pt 2):433-8. doi: 10.1099/0022-1317-69-2-433. J Gen Virol. 1988. PMID: 2828517
• Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
  Field HJ, Lay E. Field HJ, et al. Antiviral Res. 1984 Apr;4(1-2):43-52. doi: 10.1016/0166-3542(84)90024-x. Antiviral Res. 1984. PMID: 6331304
• Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
  Klein RJ. Klein RJ. Am J Med. 1982 Jul 20;73(1A):138-42. doi: 10.1016/0002-9343(82)90079-1. Am J Med. 1982. PMID: 6285703 Review.
• Herpes simplex virus latency in the nervous system--a new model.
  Steiner I, Kennedy PG. Steiner I, et al. Neuropathol Appl Neurobiol. 1991 Dec;17(6):433-40. doi: 10.1111/j.1365-2990.1991.tb00747.x. Neuropathol Appl Neurobiol. 1991. PMID: 1666173 Review.

Cited by

• "Non-Essential" Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review.
  Dogrammatzis C, Waisner H, Kalamvoki M. Dogrammatzis C, et al. Viruses. 2020 Dec 23;13(1):17. doi: 10.3390/v13010017. Viruses. 2020. PMID: 33374862 Free PMC article. Review.
• Analysis of Herpes Simplex Virus Reactivation in Explant Reveals a Method-Dependent Difference in Measured Timing of Reactivation.
  Doll JR, Sawtell NM. Doll JR, et al. J Virol. 2017 Jul 27;91(16):e00848-17. doi: 10.1128/JVI.00848-17. Print 2017 Aug 15. J Virol. 2017. PMID: 28637763 Free PMC article.
• Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.
  Sainz B Jr, Halford WP. Sainz B Jr, et al. J Virol. 2002 Nov;76(22):11541-50. doi: 10.1128/jvi.76.22.11541-11550.2002. J Virol. 2002. PMID: 12388715 Free PMC article.
• PrP(c) expression influences the establishment of herpes simplex virus type 1 latency.
  Thackray AM, Bujdoso R. Thackray AM, et al. J Virol. 2002 Mar;76(5):2498-509. doi: 10.1128/jvi.76.5.2498-2509.2002. J Virol. 2002. PMID: 11836428 Free PMC article.
• Reduced herpes simplex virus type 1 latency in Flt-3 ligand-treated mice is associated with enhanced numbers of natural killer and dendritic cells.
  Smith JR, Thackray AM, Bujdoso R. Smith JR, et al. Immunology. 2001 Mar;102(3):352-8. doi: 10.1046/j.1365-2567.2001.01180.x. Immunology. 2001. PMID: 11298835 Free PMC article.

References

1. 1. Virology. 1964 Apr;22:493-502 - PubMed
2. 1. Virology. 1962 Jun;17:225-32 - PubMed
3. 1. Nature. 1962 Sep 8;195:1028-9 - PubMed
4. 1. Infect Immun. 1977 Jun;16(3):842-8 - PubMed
5. 1. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716-20 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations